47. Psychedelics for Palliative Care with Dr Margaret Ross

The Drug Science Podcast

Innhold levert av Drug Science. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Drug Science eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.

2+ y ago 40:17

MP3•Episoder hjem

Dr Margaret Ross is a Senior Clinical Psychologist and Psychotherapist from Melbourne, Australia and the Chief Principal Investigator for Australia’s first psilocybin assisted psychotherapy study.

Throughout her career, her main focus has been youth mental health and more recently cancer and palliative care. Following working as a research psychologist and clinical trial coordinator for The University of Melbourne and Orygen Youth Health, Margaret decided to move into researching alternatives for her oncology patients who were terrified of dying and experiencing existential distress in the face of their diagnosis.

After seeing the compelling results of US-based research into the use of psilocybin assisted therapy for patients with existential distress in the face of terminal cancer, she decided to set on a fight so that similar treatments would soon become an option within Australia.

Have a listen to this week’s episode in which professor Nutt and Dr Ross talk about the land of Golden Wattle - a DMT-rich plant - fighting for its Drug policies being based on Science.

Recent Australian TGA Independent Expert Panel on MDMA and psilocybin consultation

Psilocybin

Randomized controlled trial (RCT)

Open label dose

Trial of Psilocybin versus Escitalopram for Depression

Drug Scheduling in the UK

Standard for the Uniform Scheduling of Medicines and Poisons (Australia)

National Health and Medical Research Council (NHMRC)

Therapeutic Goods Administration (TGA)

Pitjantjatjara

LSD

★ Support this podcast ★

130 episoder